Effects of early and late chronic pressure overload on extracellular matrix remodeling

Hypertension Research

Volumn 31, Issue 6, 2008, Pages 1225-1231

  Lin, Jing ^a   Davis, Harrison B ^a   Dai, Quixia ^a   Chou, Youn Min ^a   Craig, Teresa ^a   Hinojosa Laborde, Carmen ^a   Lindsey, Merry L ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Aging; Hypertension; Hypertrophy; Matrix metalloproteinases; Tissue inhibitor of metalloproteinase

Indexed keywords

COLLAGEN; FIBRONECTIN; GELATINASE B; MACROPHAGE ELASTASE; MATRILYSIN; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 14; NEUTROPHIL COLLAGENASE; SCLEROPROTEIN; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

AGE; AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CHRONIC DISEASE; CONTROLLED STUDY; DAHL SALT SENSITIVE RAT; DISEASE ASSOCIATION; FIBROSIS; HEART FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART WEIGHT; HYPERTENSION; IMMUNOBLOTTING; NONHUMAN; PATHOGENESIS; PHASE TRANSITION; PHENOTYPE; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN METABOLISM; RAT;

ANIMALS; CHRONIC DISEASE; EXTRACELLULAR MATRIX; FEMALE; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; IMMUNOBLOTTING; MATRIX METALLOPROTEINASE 12; MATRIX METALLOPROTEINASE 14; RATS; RATS, INBRED DAHL; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 48349145875     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1291/hypres.31.1225     Document Type: Article

References (21)

1. Varagic J, Susic D, Frohlich E: Heart, aging, and hypertension. Curr Opin Cardiol 2001; 16: 336-341.
2. Stroud JD, Baicu CF, Barnes MA, Spinale FG, Zile MR: Viscoelastic properties of pressure overload hypertrophied myocardium: effect of serine protease treatment. Am J Physiol Heart Circ Physiol 2002; 282: H2324-H2335.
3. Janicki JS, Brower GL, Gardner JD, Chancey AL, Stewart JA Jr: The dynamic interaction betwem matrix metalloproteinase activity and adverse myocardal remodeling. Heart Fail Rev 2004; 9: 33-42.
4. Klotz S, Hay I, Zhang G, Maurer M, Wang J, Burkhoff D: Development of heart failure in chronic hypertensive Dahl rats: focus on heart failure with preserved ejection fraction. Hypertension 2006; 47: 901-911.
5. Hinojosa-Laborde C, Craig T, Zheng W, Ji H, Haywood JR, Sandberg K: Ovariectomy augments hypertension in aging female Dahl salt-sensitive rats. Hypertension 2004; 44: 405-409.
6. Kurtz TW, Morris RJ: Hypertension in the recently weaned Dahl salt-sensitive rat despite a diet deficient in sodium chloride. Science 1985; 230: 808-810.
7. Kobayashi N, Nakano S, Mori Y, Kobayashi T, Tsubokou Y, Matsuoka H: Benidipine inhibits expression of ET-1 and TGF-beta1 in Dahl salt-sensitive hypertensive rats. Hypertens Res 2001; 24: 241-250.
8. Hinojosa-Laborde C, Lange D, Haywood J: Role of female sex hormones in the development and reversal of Dahl hypertension. Hypertension 2000; 35: 484-489.
9. Walsh BJ, Thornton SC, Penny R, Breit SN: Microplate reader-based quantitation of collagens. Anal Biochem 1992; 203: 187-190.
10. Marotta M, Martino G: Sensitive spectrophotometric method for the quantitative estimation of collagen. Anal Biochem 1985; 150: 86-90.
11. Shapiro SS: How to Test Normality and Other Distributional Assumptions. Milwaukee, American Society for Quality Control, 1990.
12. Lopez B, Gonzalez A, Diez J: Role of matrix metalloproteinases in hypertension-associated cardiac fibrosis. Curr Opin Nephrol Hypertens 2004; 13: 197-204.
13. Tsuruda T, Costello-Boerrigter LC, Burnett JC Jr: Matrix metalloproteinases: pathways of induction by bioactive molecules. Heart Fail Rev 2004; 9: 53-61.
14. Fedak PW, Smookler DS, Kassiri Z, et al: TIMP-3 deficiency leads to dilated cardiomyopathy. Circulation 2004; 110: 2401-2409.
15. Lindsey ML, Goshorn DK, Squires CE, et al: Age-dependent changes in myocardial matrix metalloproteinase/tissue inhibitor of metalloproteinase profiles and fibroblast function. Cardiovasc Res 2005; 66: 410-419.
16. Lopez B, Querejeta R, Varo N, et al: Usefulness of serum carboxy-terminal propeptide of procollagen type I in assessment of the cardioreparative ability of antihypertensive treatment in hypertensive patients. Circulation 2001; 104: 286-291.
17. Lopez B, Gonzalez A, Varo N, Laviades C, Querejeta R, Diez J: Biochemical assessment of myocardial fibrosis in hypertensive heart disease. Hypertension 2001; 38: 1222-1226.
18. Eleftheriades EG, Durand JB, Ferguso AG, Engelmann GL, Jones SB, Samarel AM: Regulation of procollagen metabolism in the pressure-overloaded rat heart. J Clin Invest 1993; 91: 1113-1122.
19. Balbin M, Fueyo A, Knauper V, et al: Collagenase-2 (MMP-8) expression in murine tissue-remodeling processes. J Biol Chem 1998; 273: 23959-23968.
20. Balbin M, Fueyo A, Knauper V, et al: Identification and enzymatic characterization of two diverging murine counterparts of human interstitial collagenase (MMP-1) expressed at sites of embryo implantaion. J Biol Chem 2001; 276: 10253-10262.
21. Ishikawa J, Kario K, Matsui Y, et al: Collagen metabolism in extracellular matrix may be involved in arterial stiffness in older hypertensive patients with left ventricular hypertrophy. Hypertens Res 2005; 28: 995-1001.